Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Alkane dehydrogenation catalyzed by a PN3P pincer iridium hydride complex

Kher Ai Chiawa, Suma Basappab, Manoj V. Maneb, Kuo-Wei Huang*c, Nicholas Long*d and Sandeep Suryabhan Gholap*a
aInstitute of Sustainability for Chemical, Energy and Environment (ISCE2), Agency of Science, Technology and Research (A*STAR), 1 Pesek Road, Jurong Island, Singapore 627833, Singapore. E-mail: sandeep_gholap@a-star.edu.sg
bCentre for Nano and Material Sciences, Jain (Deemed-to-be University), Bangalore, Karnataka 562112, India
cCenter for Renewable Energy and Storage Technologies, KAUST Catalysis Platform, and Division of Physical Science and Engineering, King Abdullah University of Science and Technology, Thuwal, 23955-6900, Saudi Arabia. E-mail: hkw@kaust.edu.sa
dDepartment of Chemistry, Imperial College London, White City Campus, London, W12 0BZ, UK. E-mail: n.long@imperial.ac.uk

Received 26th May 2026 , Accepted 26th May 2026

First published on 27th May 2026


Abstract

The use of an iridium-based pincer complex, specifically the PN3P pincer ligand backbone, for an efficient alkane dehydrogenation reaction is explored. Herein, we investigate the catalytic performance of a PN3P pincer iridium dihydride complex (Ir2) in the dehydrogenation reaction of cyclooctane to cyclooctene. With 0.1 mol% of Ir2, cyclooctane with tert-butylethylene (TBE) as a hydrogen acceptor and NaOtBu as a base, we achieved conversion up to 55% of tert-butylethylene (TBE) with a TON up to 546. These results highlight the potential of PN3P pincer iridium dihydride complexes as robust catalysts for selective alkane dehydrogenation under mild reaction conditions. Furthermore, DFT calculations strongly support our proposed mechanism.


Alkane dehydrogenation (AD) is one of the most important reactions in the petrochemical industry as it uses abundant alkane to produce valuable olefins that are chemically versatile and can act as intermediates in higher value alkane synthesis through olefin coupling.1,2 This reaction can also serve as an alternative pathway for high-temperature steam cracking of alkanes, which is energy-consuming and produces several undesirable side-products.3 In the case of alkane dehydrogenation, molecular hydrogen (H2) is produced as the primary by-product along with olefins. H2 is one of the rising energy carriers owing to its high energy density and environmentally benign nature.4 While significant efforts have been devoted to hydrogen production, such as via water splitting,5a methane pyrolysis5b and biomass gasification,5c AD could eventually also serve as an attractive alternative pathway for H2 generation. Despite the attractive advantages of the dehydrogenation of alkanes to alkenes and H2, it is a highly endothermic process,6 and this characteristic is a serious hindrance to the wide implementation of this reaction.

There are some examples of metal complexes developed over the past few decades for the dehydrogenation of alkanes, including those used with hydrogen acceptors, UV and irradiation.7,8 However, those complexes that contain a PCP pincer-type ligand utilized with a hydrogen acceptor have emerged at the top, outperforming the others in terms of stability, TON and selectivity.2,9 Pincer ligands incorporating iridium are often used in catalytic dehydrogenation systems given their outstanding catalytic activity and stability.7,10–15 Over the past decade, the high-valent oxidation state of iridium has been extensively explored for the catalytic dehydrogenation of alkanes.16–23

Early work by Jensen and Kaska in 1996 demonstrated the potential of such systems.16a They first synthesized complex 2 from 1 in the presence of H2 and LiBEt3H (Scheme 1), where the iridium dihydride complex 2 showed greater stability with no observable decomposition over a week; whereas the hydrochloride precursor 1 showed significant decomposition after 24 h. These foundational studies have established the basis of pincer–iridium catalysts, enabling further detailed mechanistic investigations on this catalytic system.


image file: d6nj01950a-s1.tif
Scheme 1 Iridium dihydride complex developed by Jensen and Kaska for the dehydrogenation of alkanes.

In 2021, Goldmann and co-worker reported alkane dehydrogenation catalysed by a (tBu4POCOP)Ir complex that proceeded through a proton-coupled electron-transfer (PCET) pathway using oxidants and bases as a proton and electron acceptor.24 In a subsequent study, they investigated the intramolecular C(sp3)–H activation during alkane dehydrogenation using (p-pyridyl-tBuPCP)–IrCl+ cation (p-pyridyl-tBuPCP = 3,5-bis(di-tertbutylphosphinomethyl)-2,6-dimethylpyridin-4-yl) complexes.25 In 2022, the same group further expanded this chemistry by reporting a bis(2-di-tert-butyl-phosphinophenyl)phosphine (tBuPHPP) iridium complex for the dehydrogenation of alkanes and demonstrated that the C–H activation using a more crowded Ir(III) complex ((tBu4PCP)IrCl+ (RPCP = 2,6-C6H3(CH2PR2) occurred intramolecularly, whereas the less crowded (iPr4PCP)IrCl+ undergoes intermolecular C–H activation.9,19

Metal–ligand cooperativity (MLC) plays an important role in C–H bond activation by enabling reversible ligand participation during catalysis.26–33 In the case of a pyridine-based pincer complex, the MLC involved in the aromatization–dearomatization of the pyridine ring results in more efficient activation of various bonds.29,34–51 PN3P pincer complexes have previously demonstrated great performance in various chemical reactions, particularly in CO2 hydrogenation52 and formic acid dehydrogenation.53 Herein, we report the catalytic activity of a PN3P–pincer iridium complex towards the dehydrogenation of alkanes (Fig. 1) and the evaluation of PN3P–pincer iridium complexes Ir1, Ir2 and Ir3 for alkane dehydrogenation (Table 1).


image file: d6nj01950a-f1.tif
Fig. 1 This work: alkane dehydrogenation catalysed by a PN3PIrH2 complex.
Table 1 Optimization of the reaction conditions towards cyclooctane dehydrogenationa

image file: d6nj01950a-u1.tif

Entry Ir cat. Base Oxidant Conv.b (%) TONb
a For the reaction, alkane (3.0 mmol), TBE (3.0 mmol), Ir cat (3.0 µmol, 0.1 mol%), base (15.0 µmol, 0.5 mol%), and oxidant (15.0 µmol, 0.5 mol%) were heated in an autoclave.b Determined by GC using mesitylene as an internal standard. TONs were calculated based on conversion of TBE determined by GC.
1 Ir1 NaOtBu 10 99
2 Ir2 NaOtBu 55 546
3 Ir3 NaOtBu 40 403
4 Ir1 NaOtBu [Fe]+[BF4] 16 157
5 Ir2 NaOtBu [Fe]+[BF4] 56 558
6 Ir3 NaOtBu [Fe]+[BF4] 42 415
7 Ir2 KOtBu 48 481
8 Ir2 KOtBu [Fe]+[BF4] 50 502


To continue the study of these PN3P–pincer iridium complexes, we synthesized Ir1, Ir2 and Ir3 according to a previously reported method.54 To test the performance of these catalysts for dehydrogenation reactions, we investigated the dehydrogenation reaction of cyclooctane (COA) as a model substrate and tert-butylethylene (TBE) as a sacrificial hydrogen acceptor. We conducted the reaction of cyclooctane (3.0 mmol) and TBE (3.0 mmol) with sodium tert-butoxide (NaOtBu) as a base and an Ir1 catalyst (3.0 µmol, 0.1 mol%). The reaction mixture was heated at 150 °C in a closed reaction tube. The reaction was monitored by GC-MS as well as 1H-NMR, and we observed after 24 h the formation of cyclooctene (COE) as well as a trace amount of the 1,3-cyclooctadiene (1,3-COD) product with an overall conversion of 10%, and a TON up to 99 was achieved (Table 1, entry 1). Next, we studied the performance of the dearomatized PN3P pincer dihydride iridium complex, Ir2. Surprisingly, the Ir2 catalyst under similar reaction conditions gave 55% conversion with a TON up to 546 (Table 1, entry 2). When the Ir3 catalyst was tested under similar reaction conditions, it gave a conversion of 40% with a TON up to 403 (Table 1, entry 3). Next, we studied the effect of oxidants to tune the oxidation potential, for example ferrocenium salts, [Fe]+[BF4], for alkane dehydrogenation reactions.24 We observed that the addition of [Fe]+[BF4] salt (Fe = Ferrocenium) to the reaction mixture enhanced the conversion for all Ir catalysts by 2–6% (Table 1, entries 4–6). Next, we examined the effect of another base, namely potassium tert-butoxide (KOtBu), with and without adding [Fe]+[BF4], which gives a slightly lower conversion as compared to NaOtBu (Table 1, entries 7 and 8).

The concentration of TBE also plays a crucial role in driving the dehydrogenation reaction of COA forward. We studied different ratios of Ir2:TBE:COA as shown in Table 2. When the reaction was carried out with a ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]100[thin space (1/6-em)]:[thin space (1/6-em)]1000 of Ir2:TBE:COA, it resulted in 5% conversion with a TON up to 3 (Table 2, entry 1). The conversion for the dehydrogenation of COA was increased to 24% when the ratio of TBE was increased to 1[thin space (1/6-em)]:[thin space (1/6-em)]500[thin space (1/6-em)]:[thin space (1/6-em)]1000, giving a TON up to 118 (Table 2, entry 2). On further increase of the ratio to 1[thin space (1/6-em)]:[thin space (1/6-em)]1000[thin space (1/6-em)]:[thin space (1/6-em)]1000, the conversion enhanced to 55% with a higher TON of up to 546 (Table 2, entry 3). This observation highlights the importance of maintaining a sufficiently high molar ratio of TBE to COA to effectively scavenge hydrogen and shift the reaction equilibrium towards dehydrogenation.

Table 2 Optimization of the reaction conditions towards cyclooctane dehydrogenationa
Entry [Ir]:COA [Ir]:TBE Temp. Conv.b (%) TONb
a For the reaction, alkane (3.0 mmol), TBE (0.3–3.0 mmol), Ir2 cat (0.1 mol%), and NaOtBu (15.0 µmol, 0.5 mol%) were heated in an autoclave.b Determined by GC using mesitylene as an internal standard. TON was calculated based on the conversion of TBE determined by GC.
1 1000 100 150 5 3
2 1000 500 150 24 118
3 1000 1000 150 55 546


Further, we explored the dehydrogenation process with KOtBu and NaOtBu as a base at different time intervals. In the case of KOtBu, the reaction was carried out initially for 4 h, and GC analysis of the reaction mixture showed a TBE conversion of 45% with a TON of up to 447 (Table 3, entry 1). Extending the reaction time to 16 h and 24 h further increased the TBE conversion to 47% and 48%, respectively, with a corresponding TON up to 466 and 481 (Table 3, entries 2 and 3). Whereas, in the case of NaOtBu as a base, 4 h, 16 h and 24 h time intervals gave 49%, 50% and 55% TBE conversion with a TON up to 499, 501 and 546, respectively (Table 3, entries 4–6). This observation suggested that extending the reaction time for the dehydrogenation reaction does not substantially improve the catalytic activity of Ir2.

Table 3 Time-dependent study for cyclooctane dehydrogenationa
Entry Time (h) Base Conv. of TBEb (%) TONb
a For the reaction, alkane (3.0 mmol), TBE (3.0 mmol), Ir2 cat (0.1 mol %), and base (15.0 µmol, 0.5 mol%) were heated in an autoclave.b Determined by GC using mesitylene as an internal standard. TON was calculated based on conversion of TBE determined by GC.
1 4 KOtBu 45 447
2 16 KOtBu 47 466
3 24 KOtBu 48 481
4 4 NaOtBu 49 499
5 16 NaOtBu 50 501
6 24 NaOtBu 55 546


Next, we studied the substrate scope using both linear and cyclic alkanes. The dehydrogenation of linear alkanes is particularly challenging because of the higher energy required for C–H activation compared to cyclic alkanes.55 We initially explored n-octane as a substrate. The reaction was carried out using n-octane, Ir2, and NaOtBu in the presence of TBE at 150 °C. After 15 h reaction time, the reaction was analyzed by GC, which gave 15% TBE conversion. Along with 1-octene as the dehydrogenated product, we also observed a trace amount of isomerized 2-octene and 1,2-dimethylcyclohexane (Table 4, entry 1). These results suggest that the linear alkane shows lower reactivity towards the dehydrogenation reaction. In contrast, a cyclic alkane, namely cyclohexane, is effectively converted to cyclohexene with a yield of 10% (Table 4, entry 2). However, complete dehydrogenation of the product to form benzene was not observed. Next, we evaluated 1,2,3,4-tetrahydronaphthalene as a bicyclic substrate. After the reaction, we observed fully dehydrogenated naphthalene as a product with 25% total conversion along with 5% of the partially dehydrogenated product, 1,4-dihydronapthalene (Table 4, entry 3).

Table 4 Substrate scope studya

image file: d6nj01950a-u2.tif

Entry Alkane Product Conv.b (%)
a For the reaction, alkane (3.0 mmol), TBE (3.0 mmol), Ir2 cat (0.1 mol %), and NaOtBu (15.0 µmol, 0.5 mol%) were heated in an autoclave.b Determined by GC using mesitylene as an internal standard.
1 n-octane image file: d6nj01950a-u3.tif 15
2 image file: d6nj01950a-u4.tif image file: d6nj01950a-u5.tif 10
3 image file: d6nj01950a-u6.tif image file: d6nj01950a-u7.tif 25


To shed light on the reaction mechanism, density functional theory (DFT) calculations were performed using the Gaussian 16 suite56 (for more details, see the supplementary information (SI)). As shown in Fig. 2, the reaction cycle begins with the formation of catalytically active species IN1, resulting from the reaction of Ir2 with the base NaOtBu along with the loss of tBuOH. The active species IN1 then forms a loosely bound adduct with TBE to form IN2, which is uphill by 5.7 kcal mol−1. Next, the first hydrogen abstraction occurs at IN2 to give IN3 via three membered transition state TS1, with a free energy barrier of 29.7 kcal mol−1. Subsequently, IN3 undergoes the second hydrogen abstraction to generate the Ir-catalyst (IN4) in its lowest oxidation state along with the alkane, having a transition state (TS2) barrier of 6.5 kcal mol−1. Then, the complex IN4 binds with the cyclooctane via σ-complex IN5, which is slightly exergonic by 3.9 kcal mol−1. Next, IN5 undergoes 1,2-addition of the C–H bond across the Ir catalyst to give cyclooctane intermediate IN6, traversing transition state TS3 with a barrier of 10.2 kcal mol−1. Finally, the β-hydride abstraction from the cyclooctyl group in IN7 leads to the formation of the cyclooctene product (COE) along with the regeneration of active catalyst IN1. These four membered transition states (TS4) required a transition state barrier of 11.8 kcal mol−1. Overall, these calculations indicate that the alkene insertion is the rate determining step of the reaction with the highest transition energy barrier of 29.7 kcal mol−1.


image file: d6nj01950a-f2.tif
Fig. 2 Free energy profile of the dehydrogenation of cyclooctane using an Ir2 catalyst. Free energy values are at the M06/SDD(Ir)/def2-TZVP(C,H,O,N,P,Na)//BP86/SDD(Ir)/def2-SVP(C,H,O,N,P,Na) level of theory. Non-essential hydrogen atoms have been omitted for the sake of clarity.

After the detailed DFT study, the possible reaction mechanism is illustrated as shown in Fig. 3.57 The first step is the insertion of TBE into the 16-electron iridium dihydride (Ir2) complex to produce alkyl hydride complex B, which undergoes reductive elimination to form the 14-electron C species. This complex activates the C–H bond of cyclooctane to give species D, followed by β-hydride elimination to yield cyclooctene and regenerate the Ir2.


image file: d6nj01950a-f3.tif
Fig. 3 Possible reaction mechanism of COA with TBE using Ir2.

Conclusion

PN3P iridium complexes Ir1, Ir2 and Ir3 with 2,6-diamino phosphine ligands have been studied towards the dehydrogenation of alkanes. The PN3P pincer iridium dihydride complex (Ir2) shows good catalytic performance in the dehydrogenation reaction of cyclooctane to cyclooctene. We achieved conversion up to 55% of tert-butylethylene (TBE) with a TON up to 546. These results highlight the potential of the PN3P pincer iridium dihydride complex as a robust catalyst for selective alkane dehydrogenation under mild reaction conditions. DFT calculations show that once the active species I formed after the treatment of NaOtBu, it forms a loosely bound adduct with TBE to form intermediate II, which is uphill by 5.7 kcal mol−1. Given that TBE is a mono substituted olefin and highly selective for hydrogenation, the dehydrogenation is turnover-limiting and alkene (TBE and COE) complexes are the resting states. When the concentration of TBE is low, the hydrogenation is turnover-limiting and the resting state is Ir2, while at high [TBE], COA dehydrogenation is turnover-limiting, and the resting state is the vinyl hydride.

Conflicts of interest

The authors declare no competing financial interest.

Data availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary information. Raw data that support the findings of the study are available from the corresponding author, upon reasonable request. Supplementary information is available. See DOI: https://doi.org/10.1039/d6nj01950a.

Acknowledgements

This work was supported by the Agency for Science, Technology and Research's (A*STAR) Council Strategic Fund C230415018 and the HTCO Seed Fund (C231218002). M. V. M. is thankful for the financial support from the ANRF (ANRF/ECRG/2024/002337/CS) and CNMS, Jain University, Bangalore, India. H. K. W. acknowledge King Abdullah University of Science and Technology (KAUST).

References

  1. J. A. Labinger, D. C. Leitch, J. E. Bercaw, M. A. Deimund and M. E. Davis, Top. Catal., 2015, 58, 494–501 CrossRef CAS.
  2. K. I. Goldberg and A. S. Goldman, Acc. Chem. Res., 2017, 50, 620–626 CrossRef CAS PubMed.
  3. (a) S. J. F. Sadrameli, Acc. Chem. Res., 2015, 140, 102–115 CAS; (b) T. Ren, M. Patel and K. Blok, Energy, 2006, 31, 425–451 CrossRef CAS; (c) M. Tuomaala, M. Hurme and A. M. Leino, Appl. Therm. Eng., 2010, 30, 45–52 CrossRef CAS.
  4. K. Mazloomi and C. Gomes, Renewable Sustainable Energy Rev., 2012, 16, 3024–3033 CrossRef CAS.
  5. (a) G. Chen and T. Zhang, cMat, 2025, 2, e12287 Search PubMed; (b) S. R. Patlolla, K. Katsu, A. Sharafian, K. Wei, O. E. Herrera and W. Mérida, Renewable Sustainable Energy Rev., 2023, 181, 113323 CrossRef CAS; (c) A. C. Chang, H. F. Chang, F. J. Lin, K. H. Lin and C. H. Chen, Int. J. Hydrogen Energy, 2011, 36, 14252–14260 CrossRef CAS.
  6. H. Afeefy, NIST Chemistry Webook 2005.
  7. (a) A. Kumar, T. M. Bhatti and A. S. Goldman, Chem. Soc. Rev., 2017, 117, 12357–12384 CrossRef CAS PubMed; (b) J. J. Sattler, J. Ruiz-Martinez, E. Santillan-Jimenez and B. M. Weckhuysen, Chem. Rev., 2014, 114, 10613–10653 CrossRef CAS PubMed; (c) Z. Nawaz, Rev. Chem. Eng., 2015, 31, 413–436 CAS.
  8. (a) M. J. Burk and R. H. Crabtree, J. Am. Chem. Soc., 1987, 109, 8025–8032 CrossRef CAS; (b) D. Shee and A. Sayari, Appl. Catal., A, 2010, 389, 155–164 CrossRef CAS.
  9. B. M. Gordon, N. Lease, T. J. Emge, F. Hasanayn and A. S. Goldman, J. Am. Chem. Soc., 2022, 144, 4133–4146 CrossRef CAS PubMed.
  10. (a) X. Jia and Z. Huang, Nat. Chem., 2016, 8, 157–161 CrossRef CAS PubMed; (b) F. Yu, R. Tao, Y. Su, G. Liu and Z. Huang, Org. Lett., 2022, 24, 4563–4568 CrossRef CAS PubMed.
  11. R. H. Crabtree, M. F. Mellea, J. M. Mihelcic and J. M. Quirk, J. Am. Chem. Soc., 1982, 104, 107–113 CrossRef CAS.
  12. M. J. Burk, R. H. Crabtree, C. P. Parnell and R. J. Uriarte, Organometallics, 1984, 3, 816–817 CrossRef CAS.
  13. M. Findlater, J. Choi, A. S. Goldman and M. Brookhart, Catal. Met. Complexes, Springer, 2012, pp. 113–141 Search PubMed.
  14. J. Choi, A. H. R. MacArthur, M. Brookhart and A. S. Goldman, Chem. Rev., 2011, 111, 1761–1779 CrossRef CAS PubMed.
  15. M. C. Haibach, S. Kundu, M. Brookhart and A. S. Goldman, Acc. Chem. Res., 2012, 45, 947–958 CrossRef CAS PubMed.
  16. (a) M. Gupta, C. Hagen, R. J. Flesher, W. C. Kaska and C. M. Jensen, Chem. Commun., 1996, 2083–2084 RSC; (b) M. Gupta, C. Hagen, R. J. Flesher, W. C. Kaska and C. M. Jensen, Chem. Commun., 1996, 2083–2084 RSC; (c) J. Belli and C. M. Jensen, Organometallics, 1996, 1532–1534 CrossRef CAS; (d) M. Gupta, C. Hagen, W. C. Kaska, R. E. Cramer and C. M. Jensen, J. Am. Chem. Soc., 1997, 119, 840–841 Search PubMed; (e) D. W. Lee, W. C. Kaska and C. M. Jensen, Organometallics, 1998, 17, 1–3 Search PubMed; (f) C. M. Jensen, Chem. Commun., 1999, 2443–2449 Search PubMed; (g) D. Morales-Morales, D. W. Lee, Z. Wang and C. M. Jensen, Organometallics, 2001, 20, 1144–1147 Search PubMed; (h) D. Morales-Morales, R. Redón, C. Yung and C. M. Jensen, Inorg. Chim. Acta, 2004, 357, 2953–2956 Search PubMed.
  17. (a) K. B. Renkema, Y. V. Kissin and A. S. Goldman, J. Am. Chem. Soc., 2003, 125, 7770–7771 Search PubMed; (b) K. E. Allen, D. M. Heinekey, A. S. Goldman and K. I. Goldberg, Organometallics, 2013, 32, 1579–1582 Search PubMed.
  18. (a) X. Zhou, S. Malakar, T. Dugan, K. Wang, A. Sattler, D. O. Marler, T. J. Emge, K. Krogh-Jespersen and A. S. Goldman, ACS Catal., 2021, 11, 14194–14209 Search PubMed; (b) A. Parihar, T. J. Emge, F. Hasanayn and A. S. Goldman, J. Am. Chem. Soc., 2025, 147, 10279–10297 CrossRef CAS PubMed.
  19. S. Kundu, Y. Choliy, G. Zhuo, R. Ahuja, T. J. Emge, R. Warmuth, M. Brookhart, K. Krogh-Jespersen and A. S. Goldman, Organometallics, 2009, 28, 5432–5444 Search PubMed.
  20. A. Kumar, T. Zhou, T. J. Emge, O. Mironov, R. J. Saxton, K. Krogh-Jespersen and A. S. Goldman, ACS Catal., 2015, 137, 9894–9911 CAS.
  21. R. Ahuja, B. Punji, M. Findlater, C. Supplee, W. Schinski, M. Brookhart and A. S. Goldman, Nat. Chem., 2011, 3, 167–171 CrossRef CAS PubMed.
  22. B. Punji, T. J. Emge and A. S. Goldman, Organometallics, 2010, 29, 2702–2709 CrossRef CAS.
  23. A. Paul and C. B. Musgrave, Angew. Chem., Int. Ed., 2007, 46, 8153 Search PubMed.
  24. A. D. R. Shada, A. J. Miller, T. J. Emge and A. S. Goldman, ACS Catal., 2021, 11, 3009–3016 CrossRef CAS.
  25. T. M. Bhatti, A. Kumar, A. Parihar, H. K. Moncy, T. J. Emge, K. M. Waldie, F. Hasanayn and A. S. Goldman, J. Am. Chem. Soc., 2023, 145, 18296–18306 Search PubMed.
  26. D. Milstein, Philos. Trans. R. Soc., A, 2015, 373, 20140189 CrossRef PubMed.
  27. M. Rauch, S. Kar, A. Kumar, L. Avram, L. J. Shimon and D. Milstein, J. Am. Chem. Soc., 2020, 142, 14513–14521 CrossRef CAS PubMed.
  28. J. R. Khusnutdinova and D. Milstein, Angew. Chem., Int. Ed., 2015, 54, 12236–12273 CrossRef CAS PubMed.
  29. T.-F. Ramspoth, J. Kootstra and S. R. Harutyunyan, Chem. Soc. Rev., 2024, 53, 3216–3223 RSC.
  30. N. E. Smith, W. H. Bernskoetter and N. Hazari, J. Am. Chem. Soc., 2019, 141, 17350–17360 Search PubMed.
  31. M. R. Elsby and R. T. Baker, Chem. Soc. Rev., 2020, 49, 8933–8987 Search PubMed.
  32. E. Ben-Ari, G. Leitus, L. J. Shimon and D. Milstein, J. Am. Chem. Soc., 2006, 128, 15390–15391 CrossRef CAS PubMed.
  33. (a) E. Fogler, J. A. Garg, P. Hu, G. Leitus, L. J. Shimon and D. Milstein, Chem. – Eur. J., 2014, 20, 15727–15731 CrossRef CAS PubMed; (b) Q.-Q. Zhou, Y.-Q. Zou, S. Kar, Y. Diskin-Posner, Y. Ben-David and D. Milstein, ACS Catal., 2021, 11, 10239–10245 CrossRef CAS PubMed.
  34. C. Gunanathan and D. Milstein, Acc. Chem. Res., 2011, 44, 588–602 Search PubMed.
  35. H. Li, B. Zheng and K.-W. Huang, Coord. Chem. Rev., 2015, 293, 116–138 Search PubMed.
  36. T. Shimbayashi and K. I. Fujita, Catalysts, 2020, 10, 635 Search PubMed.
  37. T. Zell and D. Milstein, Acc. Chem. Res., 2015, 48, 1979–1994 Search PubMed.
  38. T. P. Gonçalves, I. Dutta and K.-W. Huang, Chem. Commun., 2021, 57, 3070–3082 RSC.
  39. Y. Pan, C. L. Pan, Y. Zhang, H. Li, S. Min, X. Guo, B. Zheng, H. Chen, A. Anders and Z. Lai, Chem. – Asian J., 2016, 11, 1357–1360 CrossRef CAS PubMed.
  40. M. H. Huang, J. Hu and K.-W. Huang, J. Chin. Chem. Soc., 2018, 65, 60–64 CrossRef CAS.
  41. H. Li, Y. Wang, Z. Lai and K.-W. Huang, ACS Catal., 2017, 7, 4446–4450 CrossRef CAS.
  42. T. Chen, H. Li, S. Qu, B. Zheng, L. He, Z. Lai, Z.-X. Wang and K.-W. Huang, Organometallics, 2014, 33, 4152–4155 CrossRef CAS.
  43. S. S. Gholap, A. Al Dakhil, P. Chakraborty, H. Li, I. Dutta, P. K. Das and K.-W. Huang, Chem. Commun., 2021, 57, 11815–11818 RSC.
  44. S. B. Dawood, P. Chakraborty, L. Yang and K.-W. Huang, Tetrahydron Lett., 2025, 167, 155664 CrossRef CAS.
  45. Y. Pan, C. L. Pan, Y. Zhang, H. Li, S. Min, X. Guo, B. Zheng, H. Chen, A. Anders and Z. Lai, Chem. – Asian J., 2016, 11, 1294 Search PubMed.
  46. M. J. Ajitha and K.-W. Huang, Organometallics, 2025, 44, 2099–2106 CrossRef CAS.
  47. S. Qu, Y. Dang, C. Song, M. Wen, K.-W. Huang and Z.-X. Wang, J. Am. Chem. Soc., 2014, 136, 4974–4991 CrossRef CAS PubMed.
  48. H. Li, T. P. Gonçalves, D. Lupp and K.-W. Huang, ACS Catal., 2019, 9, 1619–1629 CrossRef CAS.
  49. T. P. Gonçalves and K.-W. Huang, J. Am. Chem. Soc., 2017, 139, 13442–13449 CrossRef PubMed.
  50. C. Guan, Y. Pan, E. P. L. Ang, J. Hu, C. Yao, M.-H. Huang, H. Li, Z. Lai and K.-W. Huang, Green Chem., 2018, 20, 4201–4205 Search PubMed.
  51. L.-P. He, T. Chen, D.-X. Xue, M. Eddaoudi and K.-W. Huang, J. Organomet. Chem., 2012, 700, 202–206 CrossRef CAS.
  52. Y. Pan, C. Guan, H. Li, P. Chakraborty, C. Zhou and K.-W. Huang, Dalton Trans., 2019, 48, 12812–12816 Search PubMed.
  53. L. Alrais, S. S. Gholap, I. Dutta, E. Abou-Hamad, B. W. J. Chen, J. Zhang, M. N. Hedhili, J.-M. Basset and K.-W. Huang, Appl. Catal., B, 2024, 342, 123439 Search PubMed.
  54. Y. Pan, C. Guan, H. Li, P. Chakraborty, C. Zhou and K.-W. Huang, Dalton Trans., 2019, 48, 12812–12816 RSC.
  55. X. Tang, X. Jia and Z. Huang, Chem. Sci., 2018, 9, 288–299 RSC.
  56. M. Frisch, et al.,. Gaussian 16, Revision C.02, Gaussian, Inc., Wallingford CT, 2019 Search PubMed.
  57. D. Bézier, C. Guan, K. Krogh-Jespersen, A. S. Goldman and M. J. Brookhart, Chem. Sci., 2016, 7, 2579–2586 RSC.

This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2026
Click here to see how this site uses Cookies. View our privacy policy here.